Log In
Print
BCIQ
Print
Print this Print this
 

ETC-1002

  Manage Alerts
Collapse Summary General Information
Company Esperion Therapeutics Inc.
DescriptionAMP-activated protein kinase (AMPK) activator and ATP citrate lyase (ACL) inhibitor
Molecular Target AMP-activated protein kinase (AMPK)
Mechanism of ActionAMP-activated protein kinase (AMPK) activator
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationHypercholesterolemia
Indication DetailsTreat hypercholesterolemia; Treat hypercholesterolemia and hypertension
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today